Atazanavir

Details

Files
Generic Name:
Atazanavir
Project Status:
Complete
Therapeutic Area:
HIV infection
Manufacturer:
Bristol Myers Squibb
Brand Name:
Reyataz
Project Line:
Reimbursement Review
Project Number:
SR0002-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
HIV infection
Recommendation Type:
List in a similar manner to other drugs in class
Final Recommendation:
Recommendation:

List in a similar manner as drug plans list other protease inhibitors as part of HIV treatment regimens.